Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction
- PMID: 2925612
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction
Abstract
The kinetics of alpha-factor Xa inhibition by antithrombin III (AT) were studied in the absence and presence of heparin (H) with high affinity for antithrombin by stopped-flow fluorometry at I 0.3, pH 7.4 and 25 degrees C, using the fluorescence probe p-aminobenzamidine (P) and intrinsic protein fluorescence to monitor the reactions. Active site binding of p-aminobenzamidine to factor Xa was characterized by a 200-fold enhancement and 4-nm blue shift of the probe fluorescence emission spectrum (lambda max 372 nm), 29-nm red shift of the excitation spectrum (lambda max 322 nm), and dissociation constant (KD) of about 80 microM. Under pseudo-first order conditions [( AT]0, [H]0, [P]0 much greater than [Xa]0), the observed factor Xa inactivation rate constant (kobs) measured by p-aminobenzamidine displacement or residual enzymatic activity increased linearly with the "effective" antithrombin concentration (i.e. corrected for probe competition) up to 300 microM in the absence of heparin, indicating a simple bimolecular process with a rate constant of 2.1 x 10(3) M-1 s-1. In the presence of heparin, a similar linear dependence of kobs on effective AT.H complex concentration was found up to 25 microM whether the reaction was followed by probe displacement or the quenching of AT.H complex protein fluorescence due to heparin dissociation, consistent with a bimolecular reaction between AT.H complex and free factor Xa with a 300-fold enhanced rate constant of 7 x 10(5) M-1 s-1. Above 25 microM AT.H complex, an increasing dead time displacement of p-aminobenzamidine and a downward deviation of kobs from the initial linear dependence on AT.H complex concentration were found, reflecting the saturation of an intermediate Xa.AT.H complex with a KD of 200 microM and a limiting rate of Xa-AT product complex formation of 140 s-1. Kinetic studies at catalytic heparin concentrations yielded a kcat/Km for factor Xa at saturating antithrombin of 7 x 10(5) M-1 s-1 in agreement with the bimolecular rate constant obtained in single heparin turnover experiments. These results demonstrate that 1) the accelerating effect of heparin on the AT/Xa reaction is at least partly due to heparin promoting the ordered assembly of antithrombin and factor Xa in an intermediate ternary complex and that 2) heparin catalytic turnover is limited by the rate of conversion of the ternary complex intermediate to the product Xa-AT complex with heparin dissociation occurring either concomitant with this step or in a subsequent faster step.
Similar articles
-
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization.J Biol Chem. 1986 Oct 5;261(28):13151-9. J Biol Chem. 1986. PMID: 3759953
-
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.J Biol Chem. 1988 Feb 5;263(4):1698-708. J Biol Chem. 1988. PMID: 3338989
-
Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.Biochemistry. 2000 Oct 3;39(39):12083-90. doi: 10.1021/bi0011126. Biochemistry. 2000. PMID: 11009624
-
Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.J Biol Chem. 1988 Oct 25;263(30):15313-8. J Biol Chem. 1988. PMID: 3262615
-
Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.J Thromb Thrombolysis. 2012 Aug;34(2):251-9. doi: 10.1007/s11239-012-0712-z. J Thromb Thrombolysis. 2012. PMID: 22453684 Review.
Cited by
-
Pentasaccharide enhances the inactivation of factor Xa by antithrombin by promoting the assembly of a Michaelis-type intermediate complex. Demonstration by rapid kinetic, surface plasmon resonance, and competitive binding studies.Biochemistry. 2006 Apr 25;45(16):5324-9. doi: 10.1021/bi060056r. Biochemistry. 2006. PMID: 16618121 Free PMC article.
-
Revisiting the Pharmacology of Unfractionated Heparin.Clin Pharmacokinet. 2019 Aug;58(8):1015-1028. doi: 10.1007/s40262-019-00751-7. Clin Pharmacokinet. 2019. PMID: 30850987 Review.
-
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):323-30. doi: 10.1042/bj3100323. Biochem J. 1995. PMID: 7646463 Free PMC article.
-
Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.Biochemistry. 2018 Aug 14;57(32):4880-4890. doi: 10.1021/acs.biochem.8b00199. Epub 2018 Jul 25. Biochemistry. 2018. PMID: 29999301 Free PMC article.
-
Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.J Biol Chem. 2007 Nov 9;282(45):32974-82. doi: 10.1074/jbc.M706529200. Epub 2007 Sep 11. J Biol Chem. 2007. PMID: 17848548 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical